Elixinol Wellness (ELLXF) Stock Price, News & Analysis

Company Overview

Elixinol Wellness Inc. is a wellness company specializing in the development, manufacture and distribution of hemp-derived cannabidiol (CBD) products and nutraceuticals. The company’s product portfolio encompasses oral formulations such as tinctures, softgels and capsules; topicals including creams, balms and salves; and consumables such as gummies and nutraceutical beverages. By integrating hemp extraction technologies with standardized dosing, Elixinol Wellness seeks to deliver consistent consumer experiences across its core brand and select private-label partnerships.

Elixinol Wellness distributes its products through a combination of direct-to-consumer e-commerce platforms, national and regional retail chains, specialty health stores and international wholesale channels. The company serves multiple geographies, with established markets in the United States and Europe, and emerging distribution networks in Asia and Australia. By leveraging third-party logistics providers and regulatory compliance teams, Elixinol Wellness aims to ensure smooth cross-border shipments and adherence to local dietary supplement standards.

Since its founding in 2014, Elixinol Wellness has invested in vertically integrated manufacturing capabilities, including an extraction and bottling facility in Colorado. The company maintains quality controls under current Good Manufacturing Practice (cGMP) guidelines and routinely tests finished goods through independent laboratories. This focus on traceability and batch-by-batch testing is designed to meet evolving consumer safety expectations and support the company’s broader goal of mainstreaming hemp-based wellness applications.

Key Stats

• Today's Range: $0.0075 to $0.0075
• 50-Day Range: $0.0040 to $0.0168
• 52-Week Range: $0.00 to $0.03
• Volume: 25 shs
• Average Volume: 7,293 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ELLXF
• CIK: N/A
• Web: www.elixinolglobal.com
• Phone: (124) 044-4585
• Fax: N/A
• Employees: 76
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A